Close
Emit® 2000 Tacrolimus Assay
Monitoring tacrolimus levels is essential to ensuring efficacy of treatment while minimizing toxic side effects and preventing organ rejection. The Emit 2000 tacrolimus method is a convenient, easy to use solution for routine tacrolimus monitoring.
Features
- Simple sample pretreatment
- Results in as little as 10 minutes
- No reagent preparation required
- No significant hematocrit interference 1,2
- Good correlation to LC/MS/MS
Advantages
- Streamlined ISD monitoring and enhanced productivity
- Excellent analytical performance for confidence in results
- Benefit from up to 4 different ISD methods on one single V-Twin® or Viva-E® drug testing system*
Assay Specifications
| Emit 2000 TACR Assay |
|
|---|---|
| Product Code | 8R019UL |
| Sample Type | EDTA Whole Blood |
| Pretreatment | Manual |
| Reportable Range | 2-30 ng/mL |
| Functional Sensitivity | 2.8 ng/mL |
| Calibration | With new reagent lot |
| Reagent Stability | Opened at 2-8° C: 12 weeks |
*Not all assays available in all countries. Check with your local Siemens Healthcare Diagnostics representative for assay availability.
Enduring Expertise for Your Immunosuppressant Drug Testing Needs.
With recognized drug testing expertise, Siemens Healthcare Diagnostics offers a comprehensive and expanding menu of tests across multiple instrument solutions to meet the immunosuppressant drug (ISD) testing needs of customers in any setting.
Learn more about the ISD offerings from Siemens
Learn more about organ transplantation
Learn more about ISD monitoring
Learn more about tacrolimus
References
1. Hermida J et al: Clinical Significance of Hematrocrit Interference in the Tacroliums II Microparticle Enzyme Immunoassay: A Tentative Approach. Clin Lab 2005; 51: 43-45.
2. LeGatt, C E S: Comparison of Two Tacrolimus Immuno assays (Emit: Viva and MEIA: IMx®) in Four Trans plant Groups. AACC 2002; Topic 19, Presentation B-7.
